10.1016j.ygyno.2017.04.014.ann

T1 Level 1144 1166 shrink large spheroids
T2 Protein 1507 1527 diffusion-controlled
T3 Protein 950 955 toxic
T4 Protein 818 819 ”
T6 Condition 1666 1671 tumor
T7 Protein 1119 1120 ”
T8 Condition 1280 1289 spheroids
T9 Protein 816 818 IP
T10 Condition 610 615 tumor
T12 Condition 682 712 large ovarian cancer spheroids
T13 Intervention 239 261 advanced-stage disease
T14 Condition 1387 1396 spheroids
T16 Condition 29 37 patients
T17 Intervention 51 73 advanced-stage disease
T18 Protein 902 903 ”
T19 Level 1274 1289 small spheroids
T20 Condition 14 37 ovarian cancer patients
T21 Protein 1491 1493 IP
T22 Protein 1117 1119 IP
T23 Protein 1341 1342 ”
T24 Protein 533 535 IP
T25 Organism 225 233 Patients
T26 Intervention 957 965 Spheroid
T27 Condition 1051 1056 tumor
T28 Level 727 754 UCI101 and A2780 cell lines
T29 Intervention 95 112 peritoneal cavity
T30 Intervention 328 346 surgical debulking
T31 Condition 474 482 patients
T32 Condition 1455 1460 tumor
T33 Condition 1666 1672 tumors
T34 Immaterial_anatomical_entity 284 300 intraperitoneal 
T35 Condition 1450 1462 intratumoral
T37 Protein 1589 1591 IP
T38 Protein 301 303 IP
T39 Condition 176 181 tumor